Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial
Open Access
- 15 January 2018
- journal article
- research article
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 18 (4), 419-430
- https://doi.org/10.1016/S1473-3099(17)30538-8
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Benznidazole and Posaconazole in Experimental Chagas Disease: Positive Interaction in Concomitant and Sequential TreatmentsPLoS Neglected Tropical Diseases, 2013
- Analytical Performance of a Multiplex Real-Time PCR Assay Using TaqMan Probes for Quantification of Trypanosoma cruzi Satellite DNA in Blood SamplesPLoS Neglected Tropical Diseases, 2013
- Combined Treatment of Heterocyclic Analogues and Benznidazole upon Trypanosoma cruzi In VivoPLOS ONE, 2011
- International Study to Evaluate PCR Methods for Detection of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease PatientsPLoS Neglected Tropical Diseases, 2011
- Tolerance and Safety of Nifurtimox in Patients with Chronic Chagas DiseaseClinical Infectious Diseases, 2010
- Tolerance of Benznidazole in Treatment of Chagas' Disease in AdultsAntimicrobial Agents and Chemotherapy, 2010
- Effects of Ravuconazole Treatment on Parasite Load and Immune Response in Dogs Experimentally Infected with Trypanosoma cruziAntimicrobial Agents and Chemotherapy, 2010
- Chagas diseaseThe Lancet, 2010
- Usefulness of PCR Strategies For Early Diagnosis of Chagas' Disease Reactivation and Treatment Follow-Up in Heart TransplantationAmerican Journal of Transplantation, 2007
- Blood culture and polymerase chain reaction for the diagnosis of the chronic phase of human infection with Trypanosoma cruziZeitschrift für Parasitenkunde, 2002